https://dermfield.com/articles/seppic-triples-natural-extract-capacity-at-french-lons-plant Derm Field en 2026-11-01T02:12:05.407Z Seppic Triples Natural Extract Capacity at French Lons Plant https://dermfield.com/articles/fda-approves-ilumya-for-active-psoriatic-arthritis-in-adults Derm Field en 2026-10-31T05:02:03.983Z FDA Approves ILUMYA for Active Psoriatic Arthritis in Adults https://dermfield.com/articles/melanoma-til-therapy-hits-62-5-response-rate-in-esmo-data Derm Field en 2026-10-30T17:06:08.384Z Melanoma TIL Therapy Hits 62.5% Response Rate in ESMO 2026 Data https://dermfield.com/articles/melanoma-trial-tests-individualized-neoantigen-therapy-at-scale Derm Field en 2026-10-30T16:41:08.336Z Melanoma Trial Tests Individualized Neoantigen Therapy at Scale https://dermfield.com/articles/starboard-extends-median-pfs-to-33-months-in-melanoma Derm Field en 2026-10-30T16:41:08.336Z STARBOARD Extends Median PFS to 33 Months in Melanoma